综合基因组分析确定了在缺铁性地方病环境中与铁相关的红细胞性和非红细胞性贫血症的多样性,以及新型致病变体。

IF 3.4 3区 医学 Q1 PATHOLOGY
Pankaj Sharma , Prateek Bhatia , Minu Singh , Manu Jamwal , Swetha Pallavelangini , Reena Das , Pankaj Malhotra , Savita V. Attri , Sarah Ducamp , Mark D. Fleming , Amita Trehan
{"title":"综合基因组分析确定了在缺铁性地方病环境中与铁相关的红细胞性和非红细胞性贫血症的多样性,以及新型致病变体。","authors":"Pankaj Sharma ,&nbsp;Prateek Bhatia ,&nbsp;Minu Singh ,&nbsp;Manu Jamwal ,&nbsp;Swetha Pallavelangini ,&nbsp;Reena Das ,&nbsp;Pankaj Malhotra ,&nbsp;Savita V. Attri ,&nbsp;Sarah Ducamp ,&nbsp;Mark D. Fleming ,&nbsp;Amita Trehan","doi":"10.1016/j.jmoldx.2024.01.011","DOIUrl":null,"url":null,"abstract":"<div><p>Inherited iron metabolism defects are possibly missed or underdiagnosed in iron-deficient endemic settings because of a lack of awareness or a methodical screening approach. Hence, we systematically evaluated anemia cases (2019 to 2021) based on clinical phenotype, normal screening tests (high-performance liquid chromatography, α gene sequencing, erythrocyte sedimentation rate, C-reactive protein, and tissue transglutaminase), and abnormal iron profile by targeted next-generation sequencing (26-gene panel) supplemented with whole-exome sequencing, multiplex ligation probe amplification/mitochondrial DNA sequencing, and chromosomal microarray. Novel variants in <em>ALAS2</em>, <em>STEAP3</em>, and <em>HSPA9</em> genes were functionally validated. A total of 290 anemia cases were screened, and 41 (14%) enrolled for genomic testing as per inclusion criteria. Comprehensive genomic testing revealed pathogenic variants in 23 of 41 cases (56%). Congenital sideroblastic anemia was the most common diagnosis (14/23; 61%), with pathogenic variations in <em>ALAS2</em> (<em>n</em> = 6), <em>SLC25A38</em> (<em>n</em> = 3), <em>HSPA9</em> (<em>n</em> = 2) and <em>HSCB</em>, <em>SLC19A2</em>, and mitochondrial DNA deletion (<em>n</em> = 1 each). Nonsideroblastic iron defects included <em>STEAP3</em>-related microcytic anemia (2/23; 8.7%) and hypotransferrenemia (1/23; 4.3%). A total of 6 of 22 cases (27%) revealed a non-iron metabolism gene defect on whole-exome sequencing. Eleven novel variants (including variants of uncertain significance) were noted in 13 cases. Genotype-phenotype correlation revealed a significant association of frameshift/nonsense/splice variants with lower presentation age (0.8 months versus 9 years; <em>P</em> &lt; 0.01) compared with missense variants. The systematic evaluation helped uncover an inherited iron defect in 41% (17/41) of cases, suggesting the need for active screening and awareness for these rare diseases in an iron-deficient endemic population.</p></div>","PeriodicalId":50128,"journal":{"name":"Journal of Molecular Diagnostics","volume":"26 5","pages":"Pages 430-444"},"PeriodicalIF":3.4000,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S152515782400031X/pdfft?md5=1ae4b2da1ba4eebc15884dfa8d76ec2e&pid=1-s2.0-S152515782400031X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting\",\"authors\":\"Pankaj Sharma ,&nbsp;Prateek Bhatia ,&nbsp;Minu Singh ,&nbsp;Manu Jamwal ,&nbsp;Swetha Pallavelangini ,&nbsp;Reena Das ,&nbsp;Pankaj Malhotra ,&nbsp;Savita V. Attri ,&nbsp;Sarah Ducamp ,&nbsp;Mark D. Fleming ,&nbsp;Amita Trehan\",\"doi\":\"10.1016/j.jmoldx.2024.01.011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Inherited iron metabolism defects are possibly missed or underdiagnosed in iron-deficient endemic settings because of a lack of awareness or a methodical screening approach. Hence, we systematically evaluated anemia cases (2019 to 2021) based on clinical phenotype, normal screening tests (high-performance liquid chromatography, α gene sequencing, erythrocyte sedimentation rate, C-reactive protein, and tissue transglutaminase), and abnormal iron profile by targeted next-generation sequencing (26-gene panel) supplemented with whole-exome sequencing, multiplex ligation probe amplification/mitochondrial DNA sequencing, and chromosomal microarray. Novel variants in <em>ALAS2</em>, <em>STEAP3</em>, and <em>HSPA9</em> genes were functionally validated. A total of 290 anemia cases were screened, and 41 (14%) enrolled for genomic testing as per inclusion criteria. Comprehensive genomic testing revealed pathogenic variants in 23 of 41 cases (56%). Congenital sideroblastic anemia was the most common diagnosis (14/23; 61%), with pathogenic variations in <em>ALAS2</em> (<em>n</em> = 6), <em>SLC25A38</em> (<em>n</em> = 3), <em>HSPA9</em> (<em>n</em> = 2) and <em>HSCB</em>, <em>SLC19A2</em>, and mitochondrial DNA deletion (<em>n</em> = 1 each). Nonsideroblastic iron defects included <em>STEAP3</em>-related microcytic anemia (2/23; 8.7%) and hypotransferrenemia (1/23; 4.3%). A total of 6 of 22 cases (27%) revealed a non-iron metabolism gene defect on whole-exome sequencing. Eleven novel variants (including variants of uncertain significance) were noted in 13 cases. Genotype-phenotype correlation revealed a significant association of frameshift/nonsense/splice variants with lower presentation age (0.8 months versus 9 years; <em>P</em> &lt; 0.01) compared with missense variants. The systematic evaluation helped uncover an inherited iron defect in 41% (17/41) of cases, suggesting the need for active screening and awareness for these rare diseases in an iron-deficient endemic population.</p></div>\",\"PeriodicalId\":50128,\"journal\":{\"name\":\"Journal of Molecular Diagnostics\",\"volume\":\"26 5\",\"pages\":\"Pages 430-444\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-02-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S152515782400031X/pdfft?md5=1ae4b2da1ba4eebc15884dfa8d76ec2e&pid=1-s2.0-S152515782400031X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Molecular Diagnostics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S152515782400031X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PATHOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Diagnostics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S152515782400031X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在缺铁性地方病流行的环境中,由于缺乏认识或筛查方法,遗传性铁代谢缺陷可能被漏诊或诊断不足。因此,我们计划根据临床表型、正常筛查测试(HPLC、α基因测序、血沉、CRP、tTG)和异常铁概况,通过靶向 NGS(26 个基因组)并辅以全外显子组、MLPA/mtDNA 测序和 CMA,对贫血病例(2019-2021 年)进行系统评估。对 ALAS2、STEAP3 和 HSPA9 基因的新变异进行了功能验证。根据纳入标准,筛选出 290 例贫血病例,其中 41 例(14%)进行了基因组检测。综合基因组检测显示,23/41(56%)个病例存在致病变异。先天性红细胞性贫血(CSA)是最常见的诊断(14/23;61%),致病变异包括 ALAS2(6)、SLC25A38(3)、HSPA9(2)以及 HSCB、SLC19A2 和 mtDNA 缺失(各 1)。非红细胞性铁缺陷包括与 STEAP3 相关的小红细胞性贫血(2/23;8.7%)和低转铁蛋白血症(1/23;4.3%)。6/22(27%)人在全外显子测序中发现了非铁代谢基因缺陷。13 个病例中共有 11 个新型变异(包括 VUS)。基因型与表型的相关性显示,框架移码/无义/剪接变异与较低的发病年龄有显著关联(0.8 个月与 9 岁相比;P-
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting

Inherited iron metabolism defects are possibly missed or underdiagnosed in iron-deficient endemic settings because of a lack of awareness or a methodical screening approach. Hence, we systematically evaluated anemia cases (2019 to 2021) based on clinical phenotype, normal screening tests (high-performance liquid chromatography, α gene sequencing, erythrocyte sedimentation rate, C-reactive protein, and tissue transglutaminase), and abnormal iron profile by targeted next-generation sequencing (26-gene panel) supplemented with whole-exome sequencing, multiplex ligation probe amplification/mitochondrial DNA sequencing, and chromosomal microarray. Novel variants in ALAS2, STEAP3, and HSPA9 genes were functionally validated. A total of 290 anemia cases were screened, and 41 (14%) enrolled for genomic testing as per inclusion criteria. Comprehensive genomic testing revealed pathogenic variants in 23 of 41 cases (56%). Congenital sideroblastic anemia was the most common diagnosis (14/23; 61%), with pathogenic variations in ALAS2 (n = 6), SLC25A38 (n = 3), HSPA9 (n = 2) and HSCB, SLC19A2, and mitochondrial DNA deletion (n = 1 each). Nonsideroblastic iron defects included STEAP3-related microcytic anemia (2/23; 8.7%) and hypotransferrenemia (1/23; 4.3%). A total of 6 of 22 cases (27%) revealed a non-iron metabolism gene defect on whole-exome sequencing. Eleven novel variants (including variants of uncertain significance) were noted in 13 cases. Genotype-phenotype correlation revealed a significant association of frameshift/nonsense/splice variants with lower presentation age (0.8 months versus 9 years; P < 0.01) compared with missense variants. The systematic evaluation helped uncover an inherited iron defect in 41% (17/41) of cases, suggesting the need for active screening and awareness for these rare diseases in an iron-deficient endemic population.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.10
自引率
2.40%
发文量
143
审稿时长
43 days
期刊介绍: The Journal of Molecular Diagnostics, the official publication of the Association for Molecular Pathology (AMP), co-owned by the American Society for Investigative Pathology (ASIP), seeks to publish high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, clinical informatics, or the description of polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods which may be applied to diagnosis or monitoring of disease or disease predisposition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信